vyndamax
Generic: tafamidis
Labeler: pfizer laboratories div pfizer incDrug Facts
Product Profile
Brand Name
vyndamax
Generic Name
tafamidis
Labeler
pfizer laboratories div pfizer inc
Dosage Form
CAPSULE, LIQUID FILLED
Routes
Active Ingredients
tafamidis 61 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0069-8730
Product ID
0069-8730_4ee63a96-9d81-4941-a641-510beb6abb81
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA212161
Listing Expiration
2027-12-31
Marketing Start
2019-08-27
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00698730
Hyphenated Format
0069-8730
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
vyndamax (source: ndc)
Generic Name
tafamidis (source: ndc)
Application Number
NDA212161 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 61 mg/1
Packaging
- 30 BLISTER PACK in 1 CARTON (0069-8730-30) / 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0069-8730-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4ee63a96-9d81-4941-a641-510beb6abb81", "openfda": {"unii": ["ZU7CF08A1A", "8FG9H9D31J"], "rxcui": ["2168534", "2168540", "2168542", "2168548"], "spl_set_id": ["1b4121ee-a733-4456-a917-be2603477839"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 CARTON (0069-8730-30) / 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0069-8730-01)", "package_ndc": "0069-8730-30", "marketing_start_date": "20190827"}], "brand_name": "Vyndamax", "product_id": "0069-8730_4ee63a96-9d81-4941-a641-510beb6abb81", "dosage_form": "CAPSULE, LIQUID FILLED", "product_ndc": "0069-8730", "generic_name": "tafamidis", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Vyndamax", "active_ingredients": [{"name": "TAFAMIDIS", "strength": "61 mg/1"}], "application_number": "NDA212161", "marketing_category": "NDA", "marketing_start_date": "20190827", "listing_expiration_date": "20271231"}